Clinical Trial Update: Imaging With 11C-erlotinib PET/CT to Identify Responders to Erlotinib Treatment in NSCLC [NA]

View source ↗

Summary

This clinical trial update describes using PET/CT imaging with 11C-erlotinib to identify which non-small cell lung cancer patients respond to erlotinib therapy,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: University of Aarhus | Conditions: Lung Cancer | NA | Status: TERMINATED